Blocking of The Prostaglandin E2 Receptor as a Therapeutic Strategy for Treatment of Breast Cancer: Promising Findings in a Mouse Model

OBJECTIVE: The study aimed to investigate the anticancer effect of E-prostanoid receptor 1 (EP1) antagonist, SC19220, alone or in combination with the COX-2 inhibitor Celecoxob(CXB)(®) in mice bearing solid Ehrlich carcinoma (SEC). METHODS: The tumors were induced in 40 female mice, which were divid...

Descripción completa

Detalles Bibliográficos
Autores principales: EL-Ashmawy, Nahla E, EL-Zamarany, Enas A, Khedr, Eman G, Selim, Hend M, Khedr, Naglaa F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9930950/
https://www.ncbi.nlm.nih.gov/pubmed/36444589
http://dx.doi.org/10.31557/APJCP.2022.23.11.3763

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9930950/
https://www.ncbi.nlm.nih.gov/pubmed/36444589
http://dx.doi.org/10.31557/APJCP.2022.23.11.3763

Ejemplares similares